Kevin Peese serves as the Director at ViiV Healthcare, where he is at the forefront of pioneering next-generation HIV therapies with a concentrated emphasis on finding a cure. With a robust background in medicinal chemistry and drug discovery, Kevin leverages his expertise to drive innovative...
Kevin Peese serves as the Director at ViiV Healthcare, where he is at the forefront of pioneering next-generation HIV therapies with a concentrated emphasis on finding a cure. With a robust background in medicinal chemistry and drug discovery, Kevin leverages his expertise to drive innovative research and development initiatives aimed at addressing the complexities of HIV treatment. His extensive experience encompasses candidate optimization, pharmacokinetics, and the resolution of challenges associated with preclinical leads, positioning him as a key player in the biotechnology landscape.
At ViiV Healthcare, Kevin leads critical projects focused on the synthesis and structure-activity relationship (SAR) of new compounds, ensuring that each candidate is meticulously evaluated for its therapeutic potential. His academic training in natural product total synthesis has equipped him with a unique perspective on synthetic organic chemistry, allowing him to explore novel pathways in drug development. Kevin's work is not only grounded in the principles of organic chemistry but also deeply intertwined with virology, enabling him to understand the intricate mechanisms of HIV and the potential for innovative therapeutic interventions.
In addition to his technical skills, Kevin is passionate about collaboration and cross-disciplinary approaches, recognizing that the fight against HIV requires a multifaceted strategy. His commitment to advancing the field of life sciences is evident in his ongoing efforts to translate scientific discoveries into viable treatment options for patients. As he continues to push the boundaries of medicinal chemistry and drug discovery, Kevin Peese remains dedicated to the ultimate goal of achieving a cure for HIV, driven by a vision of improved health outcomes for individuals worldwide.
